My legislation to provide grants for further research into the use of psychedelics to treat active-duty service members suffering from PTSD and TBI was passed by Congress this week as part of the NDAA.
For years, veterans and private sector citizens have had access to similar clinical trials, with phenomenal results. Recent Phase 3 clinical trials with MDMA found that 86% of the study participants had reduced PTSD symptoms and 71% didn't even qualify as having PTSD anymore. I personally know many veterans whose lives were saved by just a few treatments.
Many active-duty service members are suffering the same demons that follow us home from war - but they cannot legally access psychedelic therapies. Their only option is to visit clinics outside the U.S. and risk being discharged from the military. Our service members deserve better.
This legislation is not about legalization or recreational use. It’s about honoring our promise to our military families and fighting back against the high incidence of suicide in the military community.